47 related articles for article (PubMed ID: 38733197)
1. Impact of obesity in the identification of the sentinel lymph node in endometrial cancer: a retrospective, monocentric study and literature review.
Insalaco G; Incognito GG; Genovese F; Gulino FA; Rivoli L; Ciancio F; Valenti G; Incognito D; Carbone L; Palumbo M
Arch Gynecol Obstet; 2024 Jun; 309(6):2779-2788. PubMed ID: 38400908
[TBL] [Abstract][Full Text] [Related]
2. Association between body mass index and lymph node metastasis among women with cervical cancer: a systematic review and network meta-analysis.
Shen T; Sun S; Li W; Wang X; Gao Y; Yang Q; Cai J
Arch Gynecol Obstet; 2024 Jun; ():. PubMed ID: 38858322
[TBL] [Abstract][Full Text] [Related]
3. Pilot testing a patient decision aid as a strategy to reduce overtreatment for older women with early-stage breast cancer.
Pesavento CM; Kazemi RJ; Kappelman A; Thompson JL; Jobin C; Wang T; Dossett LA
Am J Surg; 2024 May; ():115774. PubMed ID: 38834420
[TBL] [Abstract][Full Text] [Related]
4. Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single-center retrospective study.
Pang J; Li L; Yin N; Dai M; Zheng S; Chen M; Xue J; Wu J
Cancer Med; 2024 May; 13(9):e7248. PubMed ID: 38733197
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis.
Chen L; Wu F; Chen X; Chen Y; Deng L; Cai Q; Wu L; Guo W; Chen M; Li Y; Zhang W; Jin X; Chen H; Nie Q; Wu X; Lin Y; Wang C; Fu F
NPJ Breast Cancer; 2023 May; 9(1):46. PubMed ID: 37258524
[TBL] [Abstract][Full Text] [Related]
6. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
7. The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.
Bonet C; Crous-Bou M; Tsilidis KK; Gunter MJ; Kaaks R; Schulze MB; Fortner RT; Antoniussen CS; Dahm CC; Mellemkjær L; Tjønneland A; Amiano P; Ardanaz E; Colorado-Yohar SM; Rodriguez-Barranco M; Tin Tin S; Agnoli C; Masala G; Panico S; Sacerdote C; May AM; Borch KB; Rylander C; Skeie G; Christakoudi S; Aune D; Weiderpass E; Dossus L; Riboli E; Agudo A
Eur J Epidemiol; 2023 May; 38(5):545-557. PubMed ID: 36988840
[TBL] [Abstract][Full Text] [Related]
8. Excess body weight: Novel insights into its roles in obesity comorbidities.
Zhang X; Ha S; Lau HC; Yu J
Semin Cancer Biol; 2023 Jul; 92():16-27. PubMed ID: 36965839
[TBL] [Abstract][Full Text] [Related]
9. Overweight, obesity and risk of multimorbidity: A systematic review and meta-analysis of longitudinal studies.
Delpino FM; Dos Santos Rodrigues AP; Petarli GB; Machado KP; Flores TR; Batista SR; Nunes BP
Obes Rev; 2023 Jun; 24(6):e13562. PubMed ID: 36929143
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Emirzeoglu L; Arici S; Sahin AB; Ocak B; Ak N; Ay S; Mammadov E; Turna H; Bilici A
Breast Care (Basel); 2023 Feb; 18(1):42-48. PubMed ID: 36876171
[TBL] [Abstract][Full Text] [Related]
11. The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor-positive breast cancer: A single-institute retrospective study.
Ozaki Y; Masuda J; Kataoka A; Kogawa T; Abe T; Morizono H; Inagaki L; Hara F; Takano T; Ueno T; Ohno S
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1695. PubMed ID: 36806718
[TBL] [Abstract][Full Text] [Related]
12. Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study.
Vesikansa A; Mehtälä J; Mutanen K; Lundqvist A; Laatikainen T; Ylisaukko-Oja T; Saukkonen T; Pietiläinen KH
Eur J Health Econ; 2023 Jul; 24(5):769-781. PubMed ID: 36063259
[TBL] [Abstract][Full Text] [Related]
13. Weight Gain after Hormone Receptor-Positive Breast Cancer.
Goyal A; Milner GE; Cimino-Mathews A; Visvanathan K; Wolff AC; Sharma D; Sheng JY
Curr Oncol; 2022 Jun; 29(6):4090-4103. PubMed ID: 35735435
[TBL] [Abstract][Full Text] [Related]
14. Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW; Schneider BP
Cancer; 2022 Jun; 128(11):2174-2181. PubMed ID: 35285940
[TBL] [Abstract][Full Text] [Related]
15. The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data.
Modi ND; Tan JQE; Rowland A; Koczwara B; Abuhelwa AY; Kichenadasse G; McKinnon RA; Wiese MD; Sorich MJ; Hopkins AM
NPJ Breast Cancer; 2021 Mar; 7(1):30. PubMed ID: 33753745
[TBL] [Abstract][Full Text] [Related]
16. Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models.
Das M; Ellies LG; Kumar D; Sauceda C; Oberg A; Gross E; Mandt T; Newton IG; Kaur M; Sears DD; Webster NJG
Nat Commun; 2021 Jan; 12(1):565. PubMed ID: 33495474
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
Kennard K; Buckley ME; Sizer LM; Larson S; Carter WB; Frazier TG; Carp NZ
Breast Cancer Res Treat; 2021 Feb; 186(1):53-63. PubMed ID: 33389405
[TBL] [Abstract][Full Text] [Related]
18. A Heart-Breast Cancer-on-a-Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by Cancer Chemotherapy.
Lee J; Mehrotra S; Zare-Eelanjegh E; Rodrigues RO; Akbarinejad A; Ge D; Amato L; Kiaee K; Fang Y; Rosenkranz A; Keung W; Mandal BB; Li RA; Zhang T; Lee H; Dokmeci MR; Zhang YS; Khademhosseini A; Shin SR
Small; 2021 Apr; 17(15):e2004258. PubMed ID: 33094918
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
